SCHEMBL13409052

SCHEMBL13409052

CC1(C)c2ccccc2N(c2ccc(-c3cc4cc(-c5ccccc5)c5ccccc5c4c4ccccc34)cc2)c2ccccc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE6D O43924 1/20 0.37
PGR P06401 4/20 0.34
KDM4E B2RXH2 3/20 0.33
MAPT P10636 3/20 0.33
MAPK1 P28482 2/20 0.33
ALDH1A1 P00352 2/20 0.33
HPGD P15428 2/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
KMT2A Q03164 3/20 0.33
MEN1 O00255 2/20 0.33
ACACA Q13085 2/20 0.32
HSD17B10 Q99714 1/20 0.32
MPI P34949 1/20 0.32
ITGB2 P05107 1/20 0.31
ICAM1 P05362 1/20 0.31
ITGAL P20701 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP2D6 P10635 1/20 0.31
ADAMTS5 Q9UNA0 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13408795 0.97 KMT2A (0.34) PDE6DPGRKDM4EMAPTMAPK1
SCHEMBL13409073 0.90 KMT2A (0.34) PDE6DPGRKDM4EMAPTMAPK1
SCHEMBL13408728 0.90 PGR (0.35) PDE6DPGRKDM4EMAPTMAPK1
SCHEMBL13409045 0.89 MEN1 (0.37) PDE6DPGRKDM4EMAPTMAPK1
SCHEMBL13408830 0.88 KMT2A (0.33) PGRKDM4EMAPTMAPK1ALDH1A1
SCHEMBL13340262 0.83 PDE6D (0.32) PDE6DPGRITGB2ICAM1ITGAL
SCHEMBL16488250 0.83 PDE6D (0.37) PDE6DPGRKDM4EMAPTMAPK1
SCHEMBL13340301 0.83 PDE6D (0.32) PDE6DPGRITGB2ICAM1ITGAL
SCHEMBL13557640 0.82 MAPT (0.34) PDE6DPGRKDM4EMAPTMAPK1
SCHEMBL13827557 0.81 FAAH (0.44) PDE6DPGRKDM4EMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100096982-A1 Novel organic electroluminescent compounds and organic electrouminescent device using the same GRACEL DISPLAY INC. (KR) 2010-04-22 US disclosed
US-20100096982-A1 Novel organic electroluminescent compounds and organic electrouminescent device using the same GRACEL DISPLAY INC. (KR) 2010-04-22 US disclosed
EP-2161319-A2 Benzo(c)phenanthrene derivatives and organic electroluminescent device using the same Gracel Display Inc. (KR) 2010-03-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100096982-A1 Novel organic electroluminescent compounds and organic electrouminescent device using the same OCIAD1, OR10J3, ORMDL3 PDE6D 381/4885PGR 3662/4885KDM4E 4170/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.